Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation

Mark H. Eckman, Jonathan Rosand, Steven M. Greenberg, Brian F. Gage

Research output: Contribution to journalArticlepeer-review

242 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation'. Together they form a unique fingerprint.

Medicine & Life Sciences